Astrazeneca (AZN) Free Cash Flow Growth (5y) (2014 - 2026)
Analysis
Astrazeneca (AZN) Free Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 618.78 Bn | 602.80 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 362.62 Bn | 362.62 Bn | - |
| 3 | General Electric | 329.79 Bn | 320.45 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.78 Bn | 248.49 Bn | 12.86 Bn |
| 5 | Citigroup | 228.38 Bn | -2,073.93 Bn | 24.75 Bn |
| 6 | Bhp | 216.07 Bn | 197.52 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 197.09 Bn | 195.06 Bn | - |
| 9 | Unilever | 139.31 Bn | 132.28 Bn | - |
| 10 | Hdfc Bank | 117.84 Bn | 80.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.19% |
| Mar 31, 2026 | 12.64% |
| Dec 31, 2025 | 9.35% |
| Sep 30, 2025 | 23.21% |
| Jun 30, 2025 | 27.01% |
| Mar 31, 2025 | 66.37% |
| Dec 31, 2024 | 34.84% |
| Sep 30, 2024 | 11.55% |
| Jun 30, 2024 | 67.11% |
| Mar 31, 2024 | 73.30% |
| Dec 31, 2023 | 25.69% |
| Jun 30, 2023 | 42.53% |
| Mar 31, 2023 | 115.34% |
| Dec 31, 2022 | 38.12% |
| Jun 30, 2022 | 10.00% |
| Mar 31, 2022 | 40.74% |
| Dec 31, 2021 | -13.44% |
| Sep 30, 2021 | 11.68% |
| Jun 30, 2021 | 18.83% |
| Mar 31, 2021 | 8.09% |